Streptogramin antibiotics represent a unique class of antibacterials i
n that each member of the class consists of at least 2 structurally un
related molecules: group A streptogramins (macrolactones) and group B
streptogramins (cyclic hexadepsipeptides). Both group A and group B st
reptogramins inhibit protein synthesis at the ribosomal level, and the
y act synergistically against many isolates, their combination generat
ing bactericidal activities and reducing the possibility of emergence
of resistant strains. The mechanisms of acquired resistance to group B
streptogramins are similar to those induced by erythromycin, but grou
p A streptogramins remain unaffected by target modifications and activ
e efflux. The pharmacokinetic parameters of group A and group B strept
ogramins in blood are quite similar. In addition, both the A and B gro
ups penetrate and accumulate in macrophages and in the bacterial veget
ations of experimental endocarditis. There are important structural an
d biological differences between the streptogramins and the macrolides
. The main differentiating features are the rapid antibacterial killin
g of streptogramins and the rarity of cross-resistance between the 2 g
roups of antibiotics.